Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR)

17 filings reported holding BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. as of Q3 2024.
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2.03M shares of 9.04M outstanding shares and own 22.4% of the company stock.
Largest 10 shareholders include Kynam Capital Management, LP (989K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (385K shares), FIL Ltd (281K shares), MILLENNIUM MANAGEMENT LLC (173K shares), Sumitomo Mitsui Trust Group, Inc. (54.3K shares), Nikko Asset Management Americas, Inc. (54.3K shares), RENAISSANCE TECHNOLOGIES LLC (32.9K shares), BANK OF AMERICA CORP /DE/ (29.3K shares), MORGAN STANLEY (10.4K shares), and SkyView Investment Advisors, LLC (10K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.